PropertyValue
is ?:annotates of
?:authorAffiliation
  • [\'Institute of Health Innovations and Outcomes Research, The Feinstein Institutes for Medical Research, Northwell Health, Manhasset, New York, United States.\', \'Department of Medicine, Donald and Barbara Zucker School of Medicine at Hofstra/Northwell, Hempstead, New York, United States.\', \'Department of Medicine, Newark Beth Israel Medical Center, Newark, New Jersey, United States.\', \'Wellspan York Hospital, York, Pennsylvania, United States.\', \'Department of Cardiology, Lenox Hill Hospital, Northwell Health, New York, New York, United States.\', \'Department of Medicine and Vascular Medicine, NorthShore University Health System, Evanston, Illinois, United States.\', \'Division of Cardiology, University of Chicago, Pritzker School of Medicine, Chicago, Illinois, United States.\', \'Evidence Based Medicine, Baycare Health System, Clearwater, Florida, United States.\', \'Division of Cardiovascular Medicine, Department of Medicine, Froedtert and Medical College of Wisconsin, Milwaukee, Wisconsin, United States.\', \'Department of Biostatistics and Informatics, Colorado School of Public Health, University of Colorado Anschutz Medical Campus, Aurora, Colorado, United States.\', \'Biostatistics, Colorado Prevention Center (CPC) Clinical Research, Aurora, Colorado, United States.\', \'Division of Cardiology, University of Colorado, School of Medicine, Aurora, Colorado, United States.\', \'Department of Cardiovascular Medicine, The Cardiovascular Institute, Mount Sinai Medical Center, New York, New York, United States.\', \'Department of Medicine, McMaster University, Hamilton, Ontario, Canada.\', \'Department of Biochemistry and Biomedical Sciences, McMaster University, Hamilton, Ontario, Canada.\', \'Thrombosis and Atherosclerosis Research Institute, Hamilton, Ontario, Canada.\']
?:citedBy
  • -1
?:creator
?:doi
  • 10.1055/a-1475-2351
?:doi
?:hasPublicationType
?:journal
  • Thrombosis and haemostasis
is ?:pmid of
?:pmid
?:pmid
  • 33823560
?:publication_isRelatedTo_Disease
?:rankingScore_SJR
  • 2.074
?:rankingScore_hIndex
  • 176
is ?:relation_isRelatedTo_publication of
?:title
  • Treatment-Dose LMWH versus Prophylactic/Intermediate Dose Heparins in High-Risk COVID-19 Inpatients: Rationale and Design of the HEP-COVID Trial.
?:type
?:year
  • 2021

Metadata

Anon_0  
expand all